PMDA — authorised 26 December 2014
- Marketing authorisation holder: Novartis Pharma
- Status: approved
🇯🇵 Cosentyx in Japan
PMDA authorised Cosentyx on 26 December 2014
Marketing authorisation
Cosentyx in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Immunology approved in Japan
Frequently asked questions
Is Cosentyx approved in Japan?
Yes. PMDA authorised it on 26 December 2014.
Who is the marketing authorisation holder for Cosentyx in Japan?
Novartis Pharma holds the Japanese marketing authorisation.